Alpelisib Pivikto Tablets 150mg

  • Product Name : Alpelisib Pivikto Tablets 150mg
  • Category : Anti Cancer
  • Manufacturer Name : Novartis
  • Trade Name : pivikto
  • Available Dosage : 150 MG
  • Packing : 28 Tablets
  • Pack Insert/Leaflet : 1 Pack (28 Tablets)
  • Ingredients : Alpelisib
  • Formulation : Tablet
  • Therapeutic use : Breast cancer
  • Production Capacity : 100000

Description:-

Introduction to Pivikto 150mg Tablets: 

A Beacon of Hope Pivikto 150mg Tablet, encapsulating the potent active ingredient Alpelisib, stands at the forefront of treating advanced cancer in men and postmenopausal women. This targeted therapy is specifically designed to combat advanced hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative cancer cells.


Precision Medicine: Tailored to Your Unique Profile


A pivotal step in commencing Pivikto 150mg Tablet is a comprehensive analysis by your physician, involving blood or tumor tissue samples. This scrutiny aims to detect the presence of PI3K mutations. A positive outcome paves the way for a personalized treatment plan, enhancing the likelihood of a positive response to this therapeutic intervention.


Applications of Pivikto 150mg Tablets: Navigating Advanced Cancer


Advanced Cancer Therapy


Pivikto 150mg Tablet takes center stage in the treatment of advanced cancer, offering a beacon of hope for patients facing this formidable adversary.


Adjunct to Hormonal Anti-Cancer Treatments


For individuals who have not achieved satisfactory responses to previous anti-cancer treatments, Pivikto 150mg Tablet assumes the role of a supportive ally. Working in tandem with other hormonal anti-cancer therapies, it endeavors to bolster treatment efficacy.


Decoding the Mechanism: Pivikto's Strategic Approach


The crux of Pivikto 150mg Tablet's efficacy lies in its interference with the activity of the phosphatidylinositol 3-kinase (PI3K) enzymean indispensable component for cancer cell survival. When PI3K undergoes mutations, it renders cancer cells more aggressive and resistant to HER2-targeted medications. Pivikto 150mg Tablet steps in as a strategic disruptor, inhibiting the impact of PI3K enzymes. By targeting and curbing the growth and proliferation of cancer cells, it emerges as a potent weapon against advanced cancer.


Synergies and Considerations: Interactions with Other Medications


In navigating your treatment journey, transparent communication with your physician regarding current or past medications is paramount. Keeping your healthcare provider informed about your medication history ensures a holistic understanding of your medical profile.